APP and Alzheimer disease: To directly measure the impact on amyloid-related processes, we cross-bred the Ms4a6d knock-out mice with AD-like transgenic line APP/PS1, and performed intracerebral microdialysis to assess Aβ clearance efficiency in 1-month-old mice before the formation of amyloid deposits.